Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
66.91
-1.26 (-1.85%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Liquidia Market Cap
Liquidia has a market cap or net worth of $5.99 billion as of September 2, 2026. Its market cap has increased by 151.32% in one year.
Market Cap
5.99B
Enterprise Value
5.89B
1-Year Change
151.32%
Ranking
Category
Stock Price
$66.91
ChartMarket Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.80M to $5.99B, an increase of 3,469.15%. That is a compound annual growth rate of 55.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 5.99B | 99.60% |
| Dec 31, 2025 | 3.00B | 201.47% |
| Dec 31, 2024 | 995.30M | 27.47% |
| Dec 29, 2023 | 780.80M | 90.07% |
| Dec 30, 2022 | 410.80M | 62.31% |
| Dec 31, 2021 | 253.10M | 127.20% |
| Dec 31, 2020 | 111.40M | 39.60% |
| Dec 31, 2019 | 79.80M | -76.20% |
| Dec 31, 2018 | 335.30M | 99.82% |
| Jul 26, 2018 | 167.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elanco Animal Health | 12.05B |
| Dr. Reddy's Laboratories | 10.27B |
| Alkermes | 7.95B |
| Hims & Hers Health | 6.73B |
| Lantheus Holdings | 6.58B |
| Amneal Pharmaceuticals | 6.11B |
| Kiniksa Pharmaceuticals International, | 6.09B |
| Amylyx Pharmaceuticals | 4.36B |